Table 1. UHRF1 gene expression values regarding the demographic and selected clinicopathological parameters in urinary bladder TCC versus control patient’s samples and differences between the urinary bladder TCC subgroups.

Patients groups	Demographic and clinicopathological patient subgroups		Patients number n (%)	UHRF1 expression (mean±SE)	Difference vs. control group (p-value)	Difference between the two subgroups (p-value)
TCC	Total		70 (100)	1.47±0.25	0.1826	/
	Gender	Male	61 (87.14)	1.53±0.28	0.3090	0.4719
		Female	9 (12.86)	1.02±0.34	0.0814
	Smoking history	No	23 (32.86)	1.56±0.48	0.2332	0.7546
		Yes	47 (67.14)	1.42±0.29	0.2664
	Tumor number	Solitary	41 (58.57)	1.75±0.36	0.0348*	0.0927
		Multiple	29 (41.43)	1.06±0.30	0.9177
	Tumor size (cm)	≤3	38 (54.29)	1.09±0.25	0.4268	0.4330
		>3	32 (45.71)	1.91±0.45	0.1275
	Grades	Low	41 (58.57)	0.72±0.11	0.9060	0.0090**
		High	29 (41.43)	2.53±0.52	0.0057**
	Stages	Non-muscle invasive	53 (75.71)	1.09±0.24	0.6222	0.0305*
		Muscle invasive	17 (24.29)	2.65±0.62	0.0087**
	Outcome	Good	44 (62.86)	0.93±0.20	0.4654	0.1127
		Poor	26 (37.14)	2.37±0.54	0.0410*
Control	Total		40 (100)	0.58±0.03	/	/
	Gender	Male	34 (85.00)	1.58±0.03	/	0.6359
		Female	6 (15.00)	1.60±0.05	/

*and**, p<0.05 and p<0.01, respectively, versus control; SE = standard error.